Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029652 |
---|---|
Receipt number | R000033884 |
Scientific Title | Efficacy and safety of glecaprevir/pibrentasvir combination tablets for patients infected with pan-genotypic hepatitis C virus |
Date of disclosure of the study information | 2017/11/01 |
Last modified on | 2021/07/27 00:29:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/10/22 13:20:43 | ||
2 | Update | 2018/01/02 14:52:41 | Recruitment status |
|
3 | Update | 2018/09/10 09:40:22 | Other related information Other related information |
|
4 | Update | 2018/11/27 10:38:48 | Publication of results |
|
5 | Update | 2020/05/22 16:20:05 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2021/07/27 00:25:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
|
7 | Update | 2021/07/27 00:25:54 | Publication of results Number of participants that the trial has enrolled |
|
8 | Update | 2021/07/27 00:29:28 | Recruitment status |